IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Cologne | Germany
T: +49 (0)221 – 420 399 25
F: +49(0)221 - 420 399 26
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Cologne | Germany
T: +49 (0)221 – 420 399 25
F: +49(0)221 - 420 399 26
E-Mail: info@iozk.de
The IOZK
The IOZK Immunotherapy
News
- Award for groundbreaking discovery in immunotherapy goes to Prof. Shimon Sakaguchi
- Symposium and Training at the IOZK: Immunotherapy in Neuro-Oncology, Friday, September 6, 2019
- Professor Volker Schirrmacher from the IOZK opened the Symposium on Tumor Immunology at Kiel University with a talk about research on oncolytic viruses in conjunction with a personalized immunotherapy for cancer.
Award for groundbreaking discovery in immunotherapy goes to Prof. Shimon Sakaguchi
/in Other announcements /by IOZKSymposium and Training at the IOZK: Immunotherapy in Neuro-Oncology, Friday, September 6, 2019
/in IOZK announcements, IOZK at conferences /by IOZKProfessor Volker Schirrmacher from the IOZK opened the Symposium on Tumor Immunology at Kiel University with a talk about research on oncolytic viruses in conjunction with a personalized immunotherapy for cancer.
/in IOZK at conferences /by IOZKInternational Journal of Oncology: “From chemotherapy to biological therapy”, Prof. Dr. Volker Schirrmacher
/in IOZK in the press /by IOZKNobel Prize in Medicine 2018 awarded for the development of new cancer therapies with checkpoint inhibitors
/in IOZK announcements, Other announcements /by rootIOZK presentation: Modulated electro-hyperthermia in the treatment of children with DIPG at the annual conference of the ESHO at the Charité in Berlin
/in IOZK announcements, IOZK at conferences /by IOZKIOZK presentation on the effects of multi-modal immunotherapy in a pontine glioma with the aid of liquid biopsy analysis
/in IOZK at conferences, Other announcements /by rootImmunotherapy for prostate cancer: Canadian research group presents the current situation
/in IOZK in the press, Other announcements /by IOZKBook published by Prof. Dr. Schirrmacher: Quo vadis cancer therapy
/in IOZK announcements, IOZK publications /by IOZKIOZK presentation by Stefaan Van Gool: Immunotherapy for diffuse intrinsic pontine glioma (DIPG), at the annual meeting of the Society for Neuro-Oncology (SNO) in San Francisco
/in IOZK announcements, IOZK at conferences /by IOZK